Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$129K Sell
787
-50
-6% -$8.31K 0.07% 127
2016
Q4
$122K Hold
837
0.07% 129
2016
Q3
$140K Buy
837
+59
+8% +$9.98K 0.08% 128
2016
Q2
$118K Buy
778
+11
+1% +$1.71K 0.07% 137
2016
Q1
$115K Hold
767
0.07% 137
2015
Q4
$125K Buy
767
+642
+514% +$101K 0.07% 146
2015
Q3
$17K Sell
125
-500
-80% -$78.8K 0.01% 235
2015
Q2
$96K Hold
625
0.06% 134
2015
Q1
$100K Hold
625
0.06% 135
2014
Q4
$100K Sell
625
-254
-29% -$39.6K 0.07% 137
2014
Q3
$123K Buy
879
+254
+41% +$33.2K 0.09% 123
2014
Q2
$74K Hold
625
0.06% 151
2014
Q1
$77K Sell
625
-81
-11% -$9.82K 0.06% 144
2013
Q4
$81K Buy
+706
New +$80.3K 0.07% 140

Other funds holding AMGN

LBA Wealth Management's AMGN Position: Q1 2017 in Review

LBA Wealth Management reduced its Amgen (AMGN) stake by 6% in Q1 2017, selling an estimated $8.31K and leaving 787 shares worth $129K. The position accounts for 0.07% of the portfolio, ranked #127.

LBA Wealth Management first reported a position in AMGN in Q4 2013 and has held it in 14 quarters since. The position peaked at $140K in Q3 2016. 1,600 funds tracked by Wall St. Rank hold AMGN as of Q1 2017.

  • LBA Wealth Management held 787 shares of Amgen worth $129K as of Q1 2017.
  • LBA Wealth Management sold 50 Amgen shares in Q1 2017, an estimated $8.31K.
  • Amgen made up 0.07% of LBA Wealth Management's portfolio in Q1 2017, its #127 holding.
  • LBA Wealth Management first reported a position in Amgen in Q4 2013 and has held it in 14 quarters since.
  • LBA Wealth Management's Amgen position peaked at $140K in Q3 2016.
  • 1,600 funds tracked by Wall St. Rank held Amgen as of Q1 2017.

Based on LBA Wealth Management's 13F filing for Q1 2017, filed 9 May 2017.